scorecardresearchGujarat Themis Biosyn Share Price Live NSE, BSE, Today - Gujarat Themis

Gujarat Themis Biosyn

BSE: 506879 | NSE: | ISIN: INE942C01045 | SECTOR: Biotechnology & Drugs

470.05 31.65 (7.22%)

13 Jun 2024, 10:29 (IST)
  • Open

    440.00
  • High

    478.00
  • Low

    438.00
  • Prev Close

    438.40
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    34.15B
  • Volume

    684.45K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    470.05

Promoter Pledge Holding - 2.34%

Promoter NameNo of SharesPercentage
Pharmaceutical Business Group (India) Ltd17,00,0002.34%

Company Description

  • Biotechnology & Drugs
  • BSE

    506879
  • NSE

  • ISIN

    INE942C01045

Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through manufacturing of the bulk drugs segment. Its product portfolio comprises Rifamycin-O and Rifamycin-S. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy). Its research and development division focuses on developing fermentation cultures.

Company Officers

  • Tapas Thakurata

    Chief Executive Officer
  • Bharat Desai

    Chief Financial Officer
  • Kim Do-Deon

    Chief Technical Officer
  • Rahul Soni

    Compliance Officer, Company Secretary